ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.99
0.00%
US Tech 100
19,896.40
0.07%
S&P 500
5,849.72
-1.76%
US Dollar vs CAD
1.44328
-0.42%
Bitcoin
83,817.13
-2.64%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Brazil
  5. BOV

  6. Bny Mellon DRN (BONY34) Share Price

Bny Mellon DRN

Bny Mellon DRN (BONY34)

BOV
515.61
8.61
(1.70%)
Closed March 04 2:55PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
515.61
Bid
330.00
Ask
755.00
Volume
154
513.06 Day's Range 515.61
267.30 52 Week Range 515.61
Market Cap
374.889B
Previous Close
507.00
Open
513.06
Last Trade
1
@
515.61
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
76
Shares Outstanding
727,078,000
Dividend Yield
1.46%
PE Ratio
14.81
Earnings Per Share (EPS)
5.96
Revenue
18.58B
Net Profit
4.34B

About Bny Mellon DRN

Sector
State Commercial Banks
Industry
National Commercial Banks - Non Islamic
Website
www.bnymellon.com
Headquarters
New York, New York, USA
Founded
2007
Bny Mellon DRN is listed in the State Commercial Banks sector of the Brazil Bovespa Exchange with ticker BONY34. The last closing price for Bny Mellon DRN was R$507. Over the last year, Bny Mellon DRN shares have traded in a share price range of R$ 267.30 to R$ 515.61.

Bny Mellon DRN currently has 727,078,000 shares outstanding. The market capitalization of Bny Mellon DRN is R$368.63 billion. Bny Mellon DRN has a price to earnings ratio (PE ratio) of 14.81.

Ask ADVFN Intelligence (AI)

BONY34 Latest News

More News
No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
117.113.43229689067498.5515.6149820504.20625DR
418.363.69230769231497.25515.61479.7162502.08269269DR
1223.164.70301553457492.45515.61450.7376493.70785183DR
26144.8739.0759022496370.74515.61370.7492448.12191136DR
52240.2187.2222222222275.4515.61267.3155339.94722305DR
156230.6180.9157894737285515.61194.4267248.06506967DR
260335.84186.816487734179.77515.61143.65301250.54192761DR

BONY34 - Frequently Asked Questions (FAQ)

What is the current Bny Mellon DRN share price?
The current share price of Bny Mellon DRN is R$ 515.61
How many Bny Mellon DRN shares are in issue?
Bny Mellon DRN has 727,078,000 shares in issue
What is the market cap of Bny Mellon DRN?
The market capitalisation of Bny Mellon DRN is BRL 368.63B
What is the 1 year trading range for Bny Mellon DRN share price?
Bny Mellon DRN has traded in the range of R$ 267.30 to R$ 515.61 during the past year
What is the PE ratio of Bny Mellon DRN?
The price to earnings ratio of Bny Mellon DRN is 14.81
What is the cash to sales ratio of Bny Mellon DRN?
The cash to sales ratio of Bny Mellon DRN is 3.46
What is the reporting currency for Bny Mellon DRN?
Bny Mellon DRN reports financial results in USD
What is the latest annual turnover for Bny Mellon DRN?
The latest annual turnover of Bny Mellon DRN is USD 18.58B
What is the latest annual profit for Bny Mellon DRN?
The latest annual profit of Bny Mellon DRN is USD 4.34B
What is the registered address of Bny Mellon DRN?
The registered address for Bny Mellon DRN is 225 LIBERTY STREET, NEW YORK, NEW YORK, 10286
What is the Bny Mellon DRN website address?
The website address for Bny Mellon DRN is www.bnymellon.com
Which industry sector does Bny Mellon DRN operate in?
Bny Mellon DRN operates in the NATIONAL COMMERCIAL BANKS - NON ISLAMIC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PDGR3PDG Realty S.A. Empreendimentos E Participacoes
R$ 0.71
(7,000.00%)
3.48M
PLAS3Plascar Participacoes Industriais Sa
R$ 7.08
(15.50%)
600
PEAB4Cia Participacoes Alianca Bahia
R$ 51.00
(13.33%)
1,000
ONCO3Oncoclinicas Brasil Servicos Medico
R$ 5.62
(11.07%)
21.17M
AMAR3Lojas Marisa S.A.
R$ 1.35
(7.14%)
721.1k
DASA11Diagnosticos da America S.A
R$ 0.24
(-20.00%)
27.2k
AZTE3Azevedo & Travassos Energia Sa
R$ 1.39
(-10.32%)
16.42M
MRFG3Marfrig Global Foods S.A
R$ 13.63
(-10.15%)
12.43M
PGMN11Empreendimentos Pague Menos S.A.
R$ 0.18
(-10.00%)
8.6k
RCSL3Recrusul Sa
R$ 3.12
(-7.14%)
836.2k
HAPV3Hapvida Participacoes Investimento SA
R$ 2.11
(-0.47%)
703.39M
CSAN3Cosan SA
R$ 7.09
(-2.07%)
226.15M
COGN3CognaEducacao SA
R$ 1.52
(-1.94%)
104.97M
CSNA3Cia Siderurgica Nacional
R$ 8.52
(-1.73%)
91.03M
BBDC4Bco Bradesco Sa
R$ 11.24
(-2.01%)
84.39M

Discussion

View Full Feed
glenn1919 glenn1919 2 minutes ago
TSLZ.......................SYTA..............................https://stockcharts.com/h-sc/ui?s=TSLZ&p=W&yr=1&mn=3&dy=0&id=p96837884856
SYTA TSLZ
Chiron Chiron 2 minutes ago
With this float it should be .003 +
BLLB
hedge_fun hedge_fun 2 minutes ago
Their focus is the 10 year. It’s going……..

as planned.

And they say, don’t fight the fed.
SMCI
Omar8 Omar8 3 minutes ago
DP,




From a post by ANT....."Jon Jon. 1st I do not have an attorney handling this I'm handling it myself. An attorney would have cost 30-40,000 already. I am familiar with the Faro's attorney a very large multi state firm where junior attorneys cost 4-500 and se
NNLX
nanobuyer nanobuyer 5 minutes ago
Yesterday and today, my attempts to access groen-tech.com result in Norton flagging the site as a potential trojan-horse. While that's not necessarily the case, it does indicate another change to the website—by whom and why? Just curious.
glenn1919 glenn1919 6 minutes ago
tslz................................................................................................p/m
TSLZ
Stino2 Stino2 6 minutes ago
To bad for the board of company that the stock is sooooo low 🤮
TNXP
gedi8 gedi8 8 minutes ago
We will see my friend. His first month in office has really hurt the market. I hope you are right

No need for personal attacks. I states an opinion. If you disagree that’s okay.
NXPL
WooptdooU WooptdooU 9 minutes ago
Why don't these GRIFTERS use their OWN money and buy at the market.... they are NOT AFRAID of the helplessly hopeful pennylongs.
LWLG
louieforpar louieforpar 9 minutes ago
Less than four one way or another. 


glenn1919 glenn1919 10 minutes ago
INLF....................................................................................p/m
INLF
uranium-pinto-beans uranium-pinto-beans 10 minutes ago
OKTA
Okta upgraded to Buy from Neutral at DA Davidson
DA Davidson analyst Rudy Kessinger upgraded Okta to Buy from Neutral with a price target of $125, up from $90. The company reported "very strong" Q4 results and meaningfully raised its fiscal 2026 guidance, the analyst tells inve
OKTA
WooptdooU WooptdooU 11 minutes ago
These scummy insiders have done NOTHING but TAKE...they must believe the helplessly hopeful pennylongs are harmless to them.
LWLG
uranium-pinto-beans uranium-pinto-beans 12 minutes ago
mmmm


https://www.bloomberg.com/news/articles/2025-03-03/citi-copy-paste-error-almost-sent-6-billion-to-wealth-account
uranium-pinto-beans uranium-pinto-beans 13 minutes ago
OKTA
Okta price target raised to $100 from $94 at Canaccord
Canaccord raised the firm's price target on Okta to $100 from $94 and keeps a Hold rating on the shares. The firm said they reported resoundingly positive Q4 results ahead of both the firm's and consensus expectations with
OKTA
uranium-pinto-beans uranium-pinto-beans 14 minutes ago
MCHP
Microchip cyclical bottom may be forming, says JPMorgan
Jefedejefes Jefedejefes 15 minutes ago
listening to your favorite song... over, and over, and over https://www.youtube.com/watch?v=BfnjX88Va4Y
EDXC
docj docj 19 minutes ago
"One example: the current CEO of Cytodyn was CMO under Nader Pourhassan the Frauder, and was fine with all his actions."

That is a false statement. It is a matter of public record how Dr JL felt about Nader. Stop trying to make it look like he was complicit with Nader's actions. It lo
CYDY
meixatech meixatech 20 minutes ago
"Oral bioavailability" is one of the most important properties in drug design and development. A high oral bioavailability reduces the amount of an administered drug necessary to achieve a desired pharmacological effect and therefore could reduce the risk of side-effects and toxicity.
RSPI
trader53 trader53 20 minutes ago
Nixon's Restaurants have not gone belly up


https://investorshub.advfn.com/uicon/155361.png?cb=636360310707230000
______________________________________________________________________


Nixon Restaurant Group Inc
is operated in Colorado ,
gp22 gp22 21 minutes ago
$ESLA @ $1.05....Given $16 one year target last week by highly regarded bio/pharma ETF...Hit $1.80s 2 weeks ago and backed off..$ESLA a repeat of Immuno $IOVA & $SMMT monster moves
Link: 9/29/24
https://finance.yahoo.com/news/estrella-immunopharma-achieves-complete-response-160000432.h
ESLA IOVA SMMT
WooptdooU WooptdooU 22 minutes ago
Grifter siraj...eom
LWLG

Your Recent History

BOV
BONY34
Bny Mellon DRN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads